This clinical trial evaluates an online Tai Chi intervention to promote smoking cessation among cancer survivors. Tai chi is a practice that involves a series of slow gentle movements and physical postures, a meditative state of mind, and controlled breathing. It is a gentle form of exercise that can be done while sitting or standing and does not involve any medications or medical procedures. Tai chi originated as an ancient martial art in China. Over the years, it has become more focused on health promotion and rehabilitation. The use of Tai Chi may be beneficial for cancer patients who want to quit smoking.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05941858.
PRIMARY OBJECTIVE:
I. To conduct a pilot trial of an online Tai Chi intervention to promote smoking cessation among cancer survivors.
SECONDARY OBJECTIVE:
I. Collect preliminary data on the implementation cost of our Tai Chi intervention for the potential of scaling up to a more extensive study that encompass a cost-effective analysis.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants receive access to the online WaQi program to practice Tai Chi supervised over 60 minutes twice a week (BIW) and home-based over 10 minutes five days a week for 8 weeks. Participants also receive a document highlighting National Cancer Institutes' (NCI) resources for quitting smoking including NCI's tollfree Quitline number, state Quitline numbers and other resources, and undergo carbon monoxide (CO) testing on study.
ARM II: Participants receive a document highlighting NCI resources for quitting smoking including NCI's tollfree Quitline number, state Quitline numbers and other resources, and undergo CO testing on study. Participants also receive an 8-week online Tai Chi self-administered teaching module subscription at the end of the study.
After completion of study intervention, participants are followed up at 1 week, 3 months, and 6 months.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationOhio State University Comprehensive Cancer Center
Principal InvestigatorCe Shang